Research from e27, e27

e27 is Asia's largest Tech media platform. We cover the latest news on emerging and disruptive businesses across the region.

Research from e27

Private Capital Markets

Thrixen Diagnostics / Private Capital Markets

<ul><li>Singapore-based startup Thrixen, which develops a diagnostics platform for infectious diseases, has secured funding, its co-founder and CEO Shavit Clein announced in a <em>LinkedIn</em><a href="https://www.linkedin.com/feed/update/urn:li:activity:7190624185373622272/" target="_blank" data-ct="28d267dcb24ef7f811746e60d0786819" rel="noopener">post</a>.</li><li>The investors are 22Health Ventures, an early-stage healthtech investment firm and biotech company Aldevron’s co-founder John Ballantyne.</li><li>The development was first <a href="https://www.businesstimes.com.sg/startups-tech/startups/health-tech-startup-thrixen-bags-us-7-million-22health-ventures-aldevron-co-founder" target="_blank" data-ct="97187674be2ef339a210336513ba0ffd" rel="noopener">reported</a> by <em>The Business Times</em>, which pegged the funding amount at US$7 million. The capital will be used to advance the development of its diagnostic technology platform.</li></ul>

Singapore-based startup Thrixen, which develops a diagnostics platform for infectious diseases, has secured funding, its co-founder and CEO Shavit Clein announced in a LinkedInpost.The investors are 22Health Ventures, an early-stage healthtech investment firm and biotech company Aldevron’s co-founder John Ballantyne.The development was first reported by The Business Times, which pegged the funding amount at US$7 million. The capital will be used to advance the development of its diagnostic technology platform.

Thrixen bags US$7M in funding to advance its diagnostics platform | e27